Loading...

Ensign Group

Nasdaq:ENSG
Snowflake Description

Excellent balance sheet with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ENSG
Nasdaq
$3B
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The last earnings update was 50 days ago. More info.


Add to Portfolio Compare Print
ENSG Share Price and Events
7 Day Returns
0.1%
NasdaqGS:ENSG
1.6%
US Healthcare
2%
US Market
1 Year Returns
48.8%
NasdaqGS:ENSG
-2%
US Healthcare
4.3%
US Market
ENSG Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Ensign Group (ENSG) 0.1% 1.9% 14.4% 48.8% 183.3% 249.9%
US Healthcare 1.6% 3.4% 2.2% -2% 26.4% 64.8%
US Market 2% 4.1% 4.2% 4.3% 43.9% 40.8%
1 Year Return vs Industry and Market
  • ENSG outperformed the Healthcare industry which returned -2% over the past year.
  • ENSG outperformed the Market in United States of America which returned 4.3% over the past year.
Price Volatility
ENSG
Industry
5yr Volatility vs Market

Value

 Is Ensign Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Ensign Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Ensign Group.

NasdaqGS:ENSG Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.1%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqGS:ENSG
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.64
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.641 (1 + (1- 21%) (42.21%))
0.902
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.9
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.902 * 5.96%)
8.11%

Discounted Cash Flow Calculation for NasdaqGS:ENSG using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Ensign Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NasdaqGS:ENSG DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 8.11%)
2019 100.07 Analyst x1 92.56
2020 141.03 Analyst x1 120.67
2021 175.65 Est @ 24.55% 139.02
2022 207.28 Est @ 18.01% 151.75
2023 235.10 Est @ 13.42% 159.21
2024 259.12 Est @ 10.22% 162.32
2025 279.77 Est @ 7.97% 162.11
2026 297.67 Est @ 6.4% 159.55
2027 313.44 Est @ 5.3% 155.40
2028 327.63 Est @ 4.53% 150.25
Present value of next 10 years cash flows $1,452.85
NasdaqGS:ENSG DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $327.63 × (1 + 2.73%) ÷ (8.11% – 2.73%)
$6,258.98
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $6,258.98 ÷ (1 + 8.11%)10
$2,870.44
NasdaqGS:ENSG Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $1,452.85 + $2,870.44
$4,323.29
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $4,323.29 / 53.52
$80.78
NasdaqGS:ENSG Discount to Share Price
Calculation Result
Value per share (USD) From above. $80.78
Current discount Discount to share price of $56.32
= -1 x ($56.32 - $80.78) / $80.78
30.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Ensign Group is available for.
Intrinsic value
30%
Share price is $56.32 vs Future cash flow value of $80.78
Current Discount Checks
For Ensign Group to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Ensign Group's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Ensign Group's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Ensign Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Ensign Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGS:ENSG PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $1.84
NasdaqGS:ENSG Share Price ** NasdaqGS (2019-06-24) in USD $56.32
United States of America Healthcare Industry PE Ratio Median Figure of 57 Publicly-Listed Healthcare Companies 21.18x
United States of America Market PE Ratio Median Figure of 3,095 Publicly-Listed Companies 17.88x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Ensign Group.

NasdaqGS:ENSG PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:ENSG Share Price ÷ EPS (both in USD)

= 56.32 ÷ 1.84

30.54x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ensign Group is overvalued based on earnings compared to the US Healthcare industry average.
  • Ensign Group is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Ensign Group's expected growth come at a high price?
Raw Data
NasdaqGS:ENSG PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 30.54x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
20.9%per year
United States of America Healthcare Industry PEG Ratio Median Figure of 43 Publicly-Listed Healthcare Companies 1.68x
United States of America Market PEG Ratio Median Figure of 2,134 Publicly-Listed Companies 1.54x

*Line of best fit is calculated by linear regression .

NasdaqGS:ENSG PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 30.54x ÷ 20.9%

1.46x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ensign Group is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Ensign Group's assets?
Raw Data
NasdaqGS:ENSG PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $11.95
NasdaqGS:ENSG Share Price * NasdaqGS (2019-06-24) in USD $56.32
United States of America Healthcare Industry PB Ratio Median Figure of 94 Publicly-Listed Healthcare Companies 2.45x
United States of America Market PB Ratio Median Figure of 5,255 Publicly-Listed Companies 1.8x
NasdaqGS:ENSG PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:ENSG Share Price ÷ Book Value per Share (both in USD)

= 56.32 ÷ 11.95

4.71x

* Primary Listing of Ensign Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ensign Group is overvalued based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Ensign Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Ensign Group has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Ensign Group expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
20.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Ensign Group expected to grow at an attractive rate?
  • Ensign Group's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Ensign Group's earnings growth is expected to exceed the United States of America market average.
  • Ensign Group's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGS:ENSG Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGS:ENSG Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 20.9%
NasdaqGS:ENSG Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 9.4%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 12.4%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGS:ENSG Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGS:ENSG Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 2,520 196 143 4
2019-12-31 2,333 167 121 4
NasdaqGS:ENSG Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 2,098 195 97
2018-12-31 2,041 210 92
2018-09-30 1,991 167 77
2018-06-30 1,948 149 71
2018-03-31 1,900 94 61
2017-12-31 1,849 73 40
2017-09-30 1,795 66 48
2017-06-30 1,751 62 45
2017-03-31 1,713 81 44
2016-12-31 1,655 74 50
2016-09-30 1,595 91 45
2016-06-30 1,518 63 48

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Ensign Group's earnings are expected to grow significantly at over 20% yearly.
  • Ensign Group's revenue is expected to grow by 9.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGS:ENSG Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Ensign Group Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:ENSG Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 2.55 2.55 2.55 1.00
2019-12-31 2.20 2.20 2.20 1.00
NasdaqGS:ENSG Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 1.84
2018-12-31 1.78
2018-09-30 1.49
2018-06-30 1.37
2018-03-31 1.19
2017-12-31 0.79
2017-09-30 0.94
2017-06-30 0.88
2017-03-31 0.86
2016-12-31 0.99
2016-09-30 0.89
2016-06-30 0.94

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Ensign Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Ensign Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Ensign Group has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Ensign Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Ensign Group's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Ensign Group's year on year earnings growth rate has been positive over the past 5 years.
  • Ensign Group's 1-year earnings growth exceeds its 5-year average (59% vs 14.9%)
  • Ensign Group's earnings growth has exceeded the US Healthcare industry average in the past year (59% vs 2.7%).
Earnings and Revenue History
Ensign Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Ensign Group Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:ENSG Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 2,097.74 96.60 105.24
2018-12-31 2,040.66 92.36 100.31
2018-09-30 1,990.59 77.21 94.92
2018-06-30 1,947.82 70.56 89.58
2018-03-31 1,899.71 60.77 84.95
2017-12-31 1,849.32 40.48 80.62
2017-09-30 1,794.66 47.61 72.60
2017-06-30 1,751.13 44.55 70.64
2017-03-31 1,713.37 43.66 73.05
2016-12-31 1,654.86 49.99 69.17
2016-09-30 1,594.97 45.25 71.60
2016-06-30 1,517.99 47.57 71.46
2016-03-31 1,418.53 49.43 67.13
2015-12-31 1,341.83 55.43 64.16
2015-09-30 1,245.54 53.34 59.41
2015-06-30 1,155.30 48.78 55.20
2015-03-31 1,094.28 37.59 50.84
2014-12-31 1,027.41 35.95 47.99
2014-09-30 987.55 37.80 47.28
2014-06-30 955.97 39.38 44.93
2014-03-31 926.01 49.77 42.82
2013-12-31 904.56 25.84 36.05
2013-09-30 878.05 15.68 36.21
2013-06-30 855.48 18.40 33.71
2013-03-31 839.32 18.58 32.97
2012-12-31 823.16 41.95 31.82
2012-09-30 805.31 49.11 31.51
2012-06-30 794.97 47.50 30.61

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Ensign Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Ensign Group used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.
  • Ensign Group's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Ensign Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Ensign Group has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Ensign Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Ensign Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Ensign Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Ensign Group's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Ensign Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Ensign Group Company Filings, last reported 2 months ago.

NasdaqGS:ENSG Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 645.00 250.79 41.86
2018-12-31 602.34 243.24 39.77
2018-09-30 572.38 255.68 55.35
2018-06-30 550.28 278.12 40.14
2018-03-31 525.94 290.48 48.69
2017-12-31 500.06 312.93 55.43
2017-09-30 487.16 295.63 49.16
2017-06-30 470.96 292.63 47.12
2017-03-31 458.31 266.63 41.34
2016-12-31 460.50 283.62 69.26
2016-09-30 437.62 170.62 47.93
2016-06-30 424.09 184.36 37.02
2016-03-31 410.20 146.27 53.37
2015-12-31 426.99 99.67 43.57
2015-09-30 411.20 69.82 44.57
2015-06-30 396.91 49.52 55.39
2015-03-31 381.70 3.36 67.60
2014-12-31 257.80 68.39 56.47
2014-09-30 244.32 3.42 45.09
2014-06-30 235.31 0.00 26.84
2014-03-31 371.81 259.12 61.99
2013-12-31 357.26 261.13 71.27
2013-09-30 341.77 214.40 49.78
2013-06-30 330.25 216.12 30.78
2013-03-31 316.92 208.53 45.91
2012-12-31 327.88 210.56 45.88
2012-09-30 330.58 202.55 36.28
2012-06-30 316.45 203.87 37.52
  • Ensign Group's level of debt (38.9%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (69.2% vs 38.9% today).
  • Debt is well covered by operating cash flow (77.7%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 11.1x coverage).
X
Financial health checks
We assess Ensign Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Ensign Group has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Ensign Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.34%
Current annual income from Ensign Group dividends. Estimated to be 0.35% next year.
If you bought $2,000 of Ensign Group shares you are expected to receive $7 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Ensign Group's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).
  • Ensign Group's dividend is below the markets top 25% of dividend payers in United States of America (3.73%).
Upcoming dividend payment

Purchase Ensign Group before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGS:ENSG Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2012 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGS:ENSG Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 0.21 1.00
2019-12-31 0.19 1.00
NasdaqGS:ENSG Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-06-20 0.190 0.335
2019-03-18 0.190 0.362
2018-12-14 0.190 0.428
2018-09-24 0.180 0.435
2018-06-18 0.180 0.483
2018-03-20 0.180 0.581
2017-12-07 0.180 0.737
2017-09-12 0.170 0.752
2017-06-14 0.170 0.809
2017-03-14 0.170 0.903
2016-12-19 0.170 0.855
2016-09-20 0.160 0.779
2016-06-15 0.160 0.796
2016-03-16 0.160 0.740
2015-12-16 0.160 0.758
2015-11-03 0.150 0.634
2015-06-16 0.150 0.635
2015-03-23 0.150 0.653
2014-11-05 0.150 0.708
2014-09-17 0.140 0.793
2014-06-17 0.140 0.845
2014-03-13 0.140 0.702
2013-12-16 0.140 0.665
2013-09-19 0.130 0.607
2013-06-18 0.130 0.683
2013-03-13 0.130 0.754
2013-02-01 0.130 0.839
2012-09-19 0.120 0.847
2012-06-18 0.120 0.834
2012-03-15 0.120 0.917
2011-12-16 0.120 0.916
2011-09-15 0.110 0.961
2011-06-15 0.110 0.866
2011-02-16 0.110 0.726
2010-12-16 0.110 0.896
2010-08-05 0.100 1.058
2010-05-24 0.100 1.144
2010-03-16 0.100 1.131
2009-12-21 0.100 1.187
2009-09-18 0.090 1.223

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ensign Group is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.
  • Ensign Group is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Ensign Group's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Ensign Group's dividends as it is not paying a notable one for United States of America.
Future Payout to shareholders
  • No need to calculate the sustainability of Ensign Group's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess Ensign Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Ensign Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Ensign Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Ensign Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Barry Port
COMPENSATION $4,236,439
AGE 44
TENURE AS CEO 0.1 years
CEO Bio

Mr. Barry R. Port serves as Chief Executive Officer and Director at The Ensign Group, Inc. since May 30, 2019. Mr. Port has been Chief Operating Officer of Ensign Services, Inc at The Ensign Group, Inc. since January 2012. Mr. Port served as President of The Flagstone Group, Inc. since September 19, 2012. Mr. Port served as President of Skilled Nursing and Assisted Living Services at The Ensign Group, Inc. since January 2012. He served as the President of Keystone Care Inc., a subsidiary of Ensign Group Inc., since March 2006. He also provided oversight and guidance to Ensign Group Inc.'s New Market Chief Executive Officer, who was responsible for three facilities in Utah and one facility in Idaho. He served as President of Skilled Nursing and Assisted Living Operations. He served as the Executive Director and in other capacities at Keystone Care Inc., Bella Vita Health & Rehab Center (formerly Desert Sky Health and Rehabilitation Center) and Skilled Nursing and Assisted Living Operations from March 2004 to March 2006. Before joining Ensign in March 2004, Mr. Port served as Manager of Corporate Agreements for Sprint Corporation from 2001 to March 2004. Mr. Port holds a B.S. from Brigham Young University and a Masters of Business Administration and a Masters of Health Services and Administration from Arizona State University.

CEO Compensation
  • Barry's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Barry's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Ensign Group management team in years:

0.1
Average Tenure
46.5
Average Age
  • The average tenure for the Ensign Group management team is less than 2 years, this suggests a new team.
Management Team

Christopher Christensen

TITLE
Executive Chairman
COMPENSATION
$6M
AGE
49
TENURE
0.1 yrs

Barry Port

TITLE
CEO & Director
COMPENSATION
$4M
AGE
44
TENURE
0.1 yrs

Roy Christensen

TITLE
Chairman Emeritus
COMPENSATION
$100K
AGE
84

Suzanne Snapper

TITLE
CFO & Executive VP
COMPENSATION
$4M
AGE
44
TENURE
9.8 yrs

Chad Keetch

TITLE
Chief Investment Officer
COMPENSATION
$3M
AGE
40
TENURE
0.1 yrs

Beverly Wittekind

TITLE
VP & General Counsel
COMPENSATION
$2M
AGE
53
TENURE
9.6 yrs

Spencer Burton

TITLE
President & COO
TENURE
0.1 yrs

Danny Walker

TITLE
Chief Executive Officer of Pennant Healthcare Inc.

Kevin Reese

TITLE
President of Keystone Healthcare Inc
TENURE
5.3 yrs
Board of Directors Tenure

Average tenure and age of the Ensign Group board of directors in years:

3
Average Tenure
62.5
Average Age
  • The tenure for the Ensign Group board of directors is about average.
Board of Directors

Christopher Christensen

TITLE
Executive Chairman
COMPENSATION
$6M
AGE
49
TENURE
0.1 yrs

Barry Port

TITLE
CEO & Director
COMPENSATION
$4M
AGE
44
TENURE
0.1 yrs

Roy Christensen

TITLE
Chairman Emeritus
COMPENSATION
$100K
AGE
84
TENURE
0.1 yrs

John Nackel

TITLE
Independent Director
COMPENSATION
$264K
AGE
66
TENURE
11 yrs

Daren Shaw

TITLE
Independent Director
COMPENSATION
$258K
AGE
61
TENURE
7.3 yrs

Lee Daniels

TITLE
Independent Director
COMPENSATION
$250K
AGE
61
TENURE
6 yrs

Barry Smith

TITLE
Independent Director
COMPENSATION
$251K
AGE
64
TENURE
5.4 yrs

Ann Blouin

TITLE
Director
COMPENSATION
$3K
AGE
65
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • Ensign Group individual insiders have only sold shares in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
05. Jun 19 Sell Beverly Wittekind Individual 03. Jun 19 03. Jun 19 -868 $53.17 $-46,154
06. Sep 18 Sell Barry Port Individual 04. Sep 18 04. Sep 18 -203 $38.62 $-7,840
X
Management checks
We assess Ensign Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Ensign Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Should You Be Adding Ensign Group (NASDAQ:ENSG) To Your Watchlist Today?

Check out our latest analysis for Ensign Group How Quickly Is Ensign Group Increasing Earnings Per Share? … So it is good to see that Ensign Group insiders have a significant amount of capital invested in the stock. … For growth investors like me, Ensign Group's raw rate of earnings growth is a beacon in the night.

Simply Wall St -

Should We Worry About The Ensign Group, Inc.'s (NASDAQ:ENSG) P/E Ratio?

Looking at earnings over the last twelve months, Ensign Group has a P/E ratio of 30.73. … See our latest analysis for Ensign Group How Do I Calculate A Price To Earnings Ratio? … The formula for P/E is: Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS) Or for Ensign Group: P/E of 30.73 = $56.66 ÷ $1.84 (Based on the year to March 2019.) Is A High Price-to-Earnings Ratio Good?

Simply Wall St -

Do Insiders Own Shares In The Ensign Group, Inc. (NASDAQ:ENSG)?

Taking a look at our data on the ownership groups (below), it's seems that institutions are noticeable on the share registry. … See our latest analysis for Ensign Group NasdaqGS:ENSG Ownership Summary, May 13th 2019 What Does The Institutional Ownership Tell Us About Ensign Group? … Insider Ownership Of Ensign Group The definition of company insiders can be subjective, and does vary between jurisdictions.

Simply Wall St -

Is The Ensign Group, Inc.'s (NASDAQ:ENSG) CEO Salary Justified?

Christopher Christensen became the CEO of The Ensign Group, Inc. … This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … How Does Christopher Christensen's Compensation Compare With Similar Sized Companies?

Simply Wall St -

Ensign Group (NASDAQ:ENSG) Shareholders Have Enjoyed An Impressive 121% Share Price Gain

But on a lighter note, a good company can see its share price rise well over 100%. … During five years of share price growth, Ensign Group achieved compound earnings per share (EPS) growth of 25% per year. … The EPS growth is more impressive than the yearly share price gain of 17% over the same period.

Simply Wall St -

What Does The Ensign Group, Inc.'s (NASDAQ:ENSG) Balance Sheet Tell Us About It?

(NASDAQ:ENSG) with its market cap of US$2.7b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … The following basic checks can help you get a picture of the company's balance sheet strength.

Simply Wall St -

A Note On The Ensign Group, Inc.'s (NASDAQ:ENSG) ROE and Debt To Equity

By way of learning-by-doing, we'll look at ROE to gain a better understanding of The Ensign Group, Inc. … One way to conceptualize this, is that for each $1 of shareholders' equity it has, the company made $0.15 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Is The Ensign Group, Inc. (NASDAQ:ENSG) A Financially Sound Company?

Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like The Ensign Group, Inc. … Let’s take a look at ENSG’s debt concentration and assess their financial liquidity to get an idea of their ability to fund strategic acquisitions and grow through cyclical pressures. … Remember this is a very top-level look that focuses exclusively on financial health, so I recommend a deeper analysis.

Simply Wall St -

Top Bear Market Investment: The Ensign Group, Inc. (NASDAQ:ENSG)

And I'm not talking about buying into speculative, high-risk stocks. … I'm talking about the well-proven, robust track record The Ensign Group, Inc.. … Check out our latest analysis for Ensign Group.

Simply Wall St -

Are The Ensign Group, Inc.’s Returns On Capital Worth Investigating?

To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Return On Capital Employed (ROCE): What is it? … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.

Simply Wall St -

Company Info

Description

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, such as daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors. The Assisted and Independent Living Services segment provides residential accommodations, activities, meals, security, housekeeping, and assistance in the activities of daily living to independent seniors. The Home Health and Hospice Services segment offers nursing, speech, occupational and physical therapists, medical social workers, and certified home health aide services; and hospice care services, including physical, spiritual, and psychosocial services comprising palliative and clinical care, education, and counseling for terminally ill individuals and their families. The company also provides mobile ancillary services that include digital x-ray, ultrasound, electrocardiograms, laboratory services, sub-acute services, and patient transportation. As of April 2, 2019, it operated 248 healthcare facilities; and 24 hospice agencies, 25 home health agencies, and 7 home care businesses in California, Arizona, Texas, Washington, Utah, Idaho, Colorado, Nevada, Iowa, Nebraska, Oregon, Wisconsin, Kansas, South Carolina, Oklahoma, and Wyoming. The Ensign Group, Inc. was founded in 1999 and is based in Mission Viejo, California.

Details
Name: The Ensign Group, Inc.
ENSG
Exchange: NasdaqGS
Founded: 1999
$3,014,210,524
53,519,363
Website: http://www.ensigngroup.net
Address: The Ensign Group, Inc.
27101 Puerta Real,
Suite 450,
Mission Viejo,
California, 92691,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS ENSG Common Stock Nasdaq Global Select US USD 09. Nov 2007
DB EGB Common Stock Deutsche Boerse AG DE EUR 09. Nov 2007
Number of employees
Current staff
Staff numbers
23,463
Ensign Group employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/25 00:10
End of day share price update: 2019/06/24 00:00
Last estimates confirmation: 2019/06/17
Last earnings filing: 2019/05/06
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.